Literature DB >> 15120165

A modified logistic model to describe gadolinium kinetics in breast tumors.

Peter J Moate1, Lawrence Dougherty, Mitchell D Schnall, Richard J Landis, Raymond C Boston.   

Abstract

A five-parameter modified logistic equation is presented that describes the signal enhancement in magnetic resonance dynamic contrast enhanced imaging (MRI-DCE). In this heuristic model, P(1) approximates the baseline signal, P(2) is related to the magnitude of the peak signal enhancement, P(3) is the approximate time of the maximum rate of increase of signal, P(4) is related to the maximum rate of signal enhancement, and P(5) is the terminal slope of the signal enhancement curve. Six breast tumors were studied that exhibited diverse patterns of signal enhancement, and in each case, estimated model parameters were well identified. Three of the model parameters, P(2), P(4) and P(5) describe attributes of the signal enhancement curve that have previously been shown to have diagnostic value with respect to breast cancer. Procedures for using the primary model parameters to derive a number of secondary parameters that may also have diagnostic value are discussed. Sensitivity analysis shows that the signal enhancement curve is highly sensitive to P(3) in the region of the signal intensity curve associated with rapid uptake of the contrast reagent. Consequently, frequent signal sampling in this time domain is indicated to enable identification of P(3) and sensitive fitting of the signal intensity curve. The advantages of this heuristic model compared to commonly used compartmental modeling approaches are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120165     DOI: 10.1016/j.mri.2004.01.025

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  9 in total

1.  A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.

Authors:  Luminita A Tudorica; Karen Y Oh; Nicole Roy; Mark D Kettler; Yiyi Chen; Stephanie L Hemmingson; Aneela Afzal; John W Grinstead; Gerhard Laub; Xin Li; Wei Huang
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI.

Authors:  Xiaobing Fan; Milica Medved; Gregory S Karczmar; Cheng Yang; Sean Foxley; Sanaz Arkani; Wendy Recant; Marta A Zamora; Hiroyuki Abe; Gillian M Newstead
Journal:  Magn Reson Imaging       Date:  2006-11-30       Impact factor: 2.546

3.  DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?

Authors:  Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Maryellen Giger; Gillian M Newstead
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

4.  Multi-slice DCE-MRI data using P760 distinguishes between metastatic and non-metastatic rodent prostate tumors.

Authors:  Xiaobing Fan; Milica Medved; Sean Foxley; Jonathan N River; Marta Zamora; Gregory S Karczmar; Claire Corot; Philippe Robert; Philippe Bourrinet
Journal:  MAGMA       Date:  2006-01-17       Impact factor: 2.310

5.  Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study.

Authors:  Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Gillian M Newstead
Journal:  Magn Reson Med       Date:  2008-04       Impact factor: 4.668

6.  Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.

Authors:  Anna G Sorace; Savannah C Partridge; Xia Li; Jack Virostko; Stephanie L Barnes; Daniel S Hippe; Wei Huang; Thomas E Yankeelov
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

7.  Sigmoid model analysis of breast dynamic contrast-enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction.

Authors:  Norikazu Koori; Tosiaki Miyati; Naoki Ohno; Hiroko Kawashima; Hiroko Nishikawa
Journal:  J Appl Clin Med Phys       Date:  2022-05-20       Impact factor: 2.243

8.  Quantitative Contrast-Enhanced Magnetic Resonance Lymphangiography of the Upper Limbs in Breast Cancer Related Lymphedema: An Exploratory Study.

Authors:  Marco Borri; Maria A Schmidt; Kristiana D Gordon; Toni A Wallace; Julie C Hughes; Erica D Scurr; Dow-Mu Koh; Martin O Leach; Peter S Mortimer
Journal:  Lymphat Res Biol       Date:  2015-03-16       Impact factor: 2.589

9.  Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI.

Authors:  Jiandong Yin; Jiawen Yang; Lu Han; Qiyong Guo; Wei Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.